Abstract
The landscape of antiviral drug discovery has undergone significant transformations in recent years, driven by advancements in molecular biology, computational tools, and a deeper understanding of host-virus interactions. This review delves into the latest developments in antiviral therapeutics, highlighting innovative strategies, emerging drug candidates, and the role of artificial intelligence in expediting drug discovery processes. By examining recent studies and clinical trials, the article provides a comprehensive overview of the current state and future directions in antiviral drug development.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2022 Dr. Sana Bardaweel (Author)